For cisplatin-DNA lesions, the polymerase η with the assistance of monoubiquitinated proliferating cell nuclear antigen (PCNA) has emerged as the main TLS polymerase that allows cancers to develop resistance to this type of chemotherapy [20,21,22]. Here, PCNA is linked to cancer.